Lymphoid tissue targeting of anti-HIV drugs using liposomes (Q45274537)

11 December 2017

Lymphoid tissue targeting of anti-HIV drugs using liposomes (English)

1 reference

11 December 2017

André Désormeaux

1

1 reference

PubMed ID

15721390

11 December 2017

Michel G Bergeron

series ordinal

2

1 reference

PubMed ID

15721390

11 December 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

11 December 2017

Methods in Enzymology

1 reference

11 December 2017

391

1 reference

11 December 2017

330-351

1 reference

Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection

11 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Liposomes as drug delivery system: a strategic approach for the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Targeting lymph nodes with liposomes bearing anti-HLA-DR Fab' fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Encapsulation of foscarnet in liposomes modifies drug intracellular accumulation, in vitro anti-HIV-1 activity, tissue distribution, and pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Multifactorial nature of human immunodeficiency virus disease: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

HIV-1 and HAART: a time to cure, a time to kill

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Immunogenicity and pharmacokinetic attributes of poly(ethylene glycol)-grafted immunoliposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Lymphoid tissues targeting of liposome-encapsulated 2',3'-dideoxyinosine

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Follicular dendritic cells and human immunodeficiency virus infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Liposomes to target the lymphatics by subcutaneous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Lymphatic uptake and biodistribution of liposomes after subcutaneous injection . IV. Fate of liposomes in regional lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Inhibition of human immunodeficiency virus type-1 replication in macrophages and H9 cells by free or liposome-encapsulated L-689,502, an inhibitor of the viral protease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Human immunodeficiency virus. Trapped but still dangerous

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

The acquisition of host-encoded proteins by nascent HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into rats

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Sterically stabilized liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Proteolytic fragmentation with high specificity of mouse immunoglobulin G. Mapping of proteolytic cleavage sites in the hinge region

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Antiviral efficacy, intracellular uptake and pharmacokinetics of free and liposome-encapsulated 2',3'-dideoxyinosine

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

Comparative pharmacokinetics, distributions in tissue, and interactions with blood proteins of conventional and sterically stabilized liposomes containing 2',3'-dideoxyinosine

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2805%2991019-7

7 January 2021

10.1016/S0076-6879(05)91019-7

Identifiers

DOI

1 reference

11 December 2017

1 reference

PubMed ID

15721390